CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 117 enrolled
Drug / intervention
Aerobic Exercise +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02000583
NCT02000583N/ACompleted
CompareCT.gov

Effect of Aerobic Exercise on Pathophysiology of PreClinical Alzheimer's Disease

University of Kansas Medical Center·interventional·Posted Dec 4, 2013·Updated Jul 28, 2020

In Brief

A clinical study evaluating Aerobic Exercise and Standard of Care for Alzheimer's Disease. Completed, enrolled 117 participants across 1 site.

Detailed Summary

The purpose of this study is to learn about the possible benefits of aerobic exercise in controlling or reducing the amount of amyloid present in the brain, reducing changes in brain structure that may lead to Alzheimer's Disease (AD), and increasing cognitive ability in individuals that have amyloid deposits and are at risk to develop AD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Disease
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 4, 2013
Enrollment StartNov 1, 2013
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 12.6 years ago

Interventions

Aerobic Exerciseother

Aerobic group participants will engage in 150 minutes of aerobic exercise over 4-5 days per week for 52 weeks

Standard of Careother

Control group participants will be provided educational materials on starting an exercise program, but will receive no formal support for their exercise program.